慢性肾病患者血运重建:CABG与PCI的系统综述与Meta分析
3年随访中CABG在主要不良心脑血管事件、心肌梗死和再次血运重建方面优于PCI,但PCI的30天死亡率更低,而CABG的卒中风险更高。
要点
- CKD合并冠心病患者血运重建需权衡PCI短期获益与CABG长期获益。
- 3年随访CABG降低主要不良心脑血管事件、心肌梗死和再次血运重建。
- PCI的30天死亡率更低,CABG的3年卒中风险更高。
核心结论
- CKD合并冠心病患者的血运重建策略应平衡PCI的短期获益与CABG的长期优势。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南并在PROSPERO注册(CRD42021238659)。
- 数据来源为PubMed、EMBASE和Cochrane,检索2000至2023年。
- 主要终点为长期主要不良心脑血管事件率,次要终点包括30天死亡率、卒中、心肌梗死和再次血运重建。
主要发现
- 3年随访中CABG组在主要不良心脑血管事件、心肌梗死和再次血运重建方面优于PCI组。
- PCI组30天死亡率低于CABG组。
- CABG组3年随访卒中风险高于PCI组。
临床怎么用
- 对CKD合并冠心病患者选择血运重建方式时,应综合评估短期手术风险与长期获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare outcomes of two different revascularization strategies in chronic kidney disease (CKD) patients: coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI). METHODS: We conducted this meta-analysis according to Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines and registered with PROSPERO (CRD42021238659), evaluated studies comparing CABG and PCI in patients with CAD and CKD (defined by KDIGO guidelines). Data were extracted from PubMed, EMBASE and Cochrane from 2000 to 2023. The primary end-point was long-term major adverse cardiovascular and cerebrovascular event rates, with secondary end-points including 30-day mortality, stroke, myocardial infarction (MI) and repeat revascularization. Statistical analyses included Kaplan-Meier estimations, Cox regression, and meta-regression to address heterogeneity. Publication bias was assessed via funnel plots. No funding was received, and the authors report no conflicts of interest. RESULTS: We included 33 studies with 402 300 patients (eGFR <60 ml/min/1.73 m2). The cohort comprised 132 314 coronary artery bypass graft and 269 986 PCI patients. Over 3 years, coronary artery bypass group provided protection against major adverse cardiac and cerebrovascular events, MI, and repeat revascularization compared to PCI. However, PCI showed better short-term outcomes, including lower 30-day mortality. Coronary artery bypass group was linked to a higher stroke risk over the 3-year follow-up. CONCLUSIONS: Revascularization strategies for CKD and coronary artery disease patients should balance PCI's short-term benefits with CABG's long-term advantages.
引用
- Grazioli V, Di Mauro M, Perocchio G, et al. Myocardial revascularization in patients with chronic kidney disease: a systematic review and meta-analysis of surgical versus percutaneous coronary revascularization. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39969961. doi:10.1093/icvts/ivaf021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。